Τόμος 24 (2010) – Τεύχος 1 – Άρθρο 9 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 24 (2010) – Issue 1 – Article 9 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Title The usefulness of the interim financial statements in the prediction of the annual results of the listed health care companies in the Athens stock exchange (ASE)
Author Niki Katostara

1st Health Region of Attica, Greek Ministry of Health and Social Solidarity, Athens, Hellas

Citation Katostara, N.: The usefulness of the interim financial statements in the prediction of the annual results of the listed health care companies in the Athens stock exchange (ASE), Epitheorese Klin. Farmakol. Farmakokinet. 24(1): 55-57 (2010)
Publication Date Accepted for publication: 2010
Full Text Language English
Order – Buy  Ηλεκτρονική Μορφή: pdf (10 €) – Digital Type: pdf (10 €) pharmakonpress[at]pharmakonpress[.]gr
Keywords Interim financial statements, Athens stock exchange, health companies, predictability of annual results
Other Terms review article
Summary Fundamental aim of this study is to evaluate the predictive ability of various financial data included in the interim (quarterly) statements regarding the annual financial results (profit or loss before tax) of the companies listed in the ASE. The material used comes from the quarterly financial statements published by companies listed in the ASE’s industry “Health” for the years 2005-2008. The results show that the volatility of the annual profit/loss before tax can be explained by the variability of the third and fourth quarter profit/loss before tax at 85.5%. Interestingly, sales are not an explanatory variable of earnings and this is a subject for future investigation.
References 1. Brown P., Niederhoffer V.: The predictive content of Quarterly earnings. Journal of Business 41: 488-497 (1968)

2. Brown L.D., Rozeff M.S.: The predictive value of interim reports for improving forecasts of future quarterly earnings. Accounting Review 54: 585-591 (1979)

3. Interim Financial Reporting: A guide to IAS 34, Deloitte, March 2009 available at: http://www.iasplus.com/standard/ias34.htm

4. Manalis G.: Half-yearly financial statements as a prediction of the annual results. Spoudai University of Pireus 50(3-4): 179-189 (2000)

5. Mavridis G.D.: Disclosed information aspects in Greek interim reports. Management Research News 25(11): 1-21 (2002)

Relative Papers

Online ISSN 1011-6575

Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:

Articles published in this Journal are Indexed or Abstracted in: • Chemical Abstracts • Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor

Τι είναι η Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση-Οδηγίες προς τους Συγγραφείς – 
What is Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition-Instrunctions to Authors

Άρθρα Δημοσιευμένα στην Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – 
Articles Published in Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Συντακτικη Επιτροπή-Editorial Board

ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ 2010 – ANNUAL SUBSCRIPTION 2010
Γλώσσα Πλήρους Κειμένου – Full Text Language Αγγλικά – English
Παραγγελία – Αγορά – Order – Buy Ηλεκτρονική Μορφή: pdf (70 €) – Digital Type: pdf (70 €) pharmakonpress[at]pharmakonpress[.]gr
Έντυπη Μορφή (70 € + έξοδα αποστολής) – Printed Type (70 € + shipping) pharmakonpress[at]pharmakonpress[.]gr

 

 

Bookmark the permalink.

Comments are closed.